This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Director of TMS
Tracey has been working as the Director of TMS at Compass Clinical Associates since 2014. She can answer any questions about TMS, including any insurance questions that you may have, as well as assist you with scheduling an appointment to meet with the doctor for a TMS evaluation.
Please fill all the marked fields